MariMed Q1 Sales $37.933M Beat $36.950M Estimate
Portfolio Pulse from Benzinga Newsdesk
MariMed (OTC:MRMD) reported Q1 sales of $37.933M, surpassing the analyst consensus estimate of $36.950M by 2.66% and marking a 10.33% increase from the previous year's sales of $34.380M.
May 08, 2024 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MariMed reported Q1 sales of $37.933M, exceeding estimates by 2.66% and showing a 10.33% increase from last year.
Beating sales estimates and showing year-over-year growth are positive indicators for a company's financial health and operational efficiency. This outperformance, especially in a competitive market, is likely to instill investor confidence and could lead to a short-term uptick in MariMed's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100